Discovering the route from inflammation to pancreatic cancer

Minerva Gastroenterologica e Dietologica

Volumn 58, Issue 4, 2012, Pages 283-297

  Momi, N ^a   Kaur, S ^a   Krishn, S R ^a   Batra, S K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Inflammation; Neoplasms; Obesity; Pancreatic neoplasms; Pancreatitis; Smoking

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ALCOHOL ABUSE; CANCER RISK; CHRONIC PANCREATITIS; DIABETES MELLITUS; DNA DAMAGE; EXTRACELLULAR MATRIX; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; OBESITY; PANCREAS CANCER; PATHOGENESIS; REVIEW; WOUND HEALING;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; BODY MASS INDEX; CHEMOKINES; DIABETES COMPLICATIONS; EARLY DIAGNOSIS; FOOD HABITS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; OBESITY; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PROGNOSIS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RISK FACTORS; SMOKING;

EID: 84873517735     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 2012,9:454-67.
3. Tuveson DA, Neoptolemos JP. Understanding metastasis in pancreatic cancer: a call for new clinical approaches. Cell 2012;148:21-3.
4. Wang DS, Wang ZQ, Zhang L, Qiu MZ, Luo HY, Ren C et al. Are risk factors associated with outcomes in pancreatic cancer? PLoS One 2012;7:e41984.
5. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010;24:349-58.
6. Whitcomb DC. Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 2004;287:G315-G319. (Pubitemid 38955250)
7. Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM et al. Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas 2006;33:364-70. (Pubitemid 44690726)
8. Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog 2012;51:53-63.
9. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009;10:88-95.
10. Rebours V, Boutron-Ruault MC, Schnee M, Ferec C, Maire F, Hammel P et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 2008;103:111-9.
11. Peng JH, Zhang F, Zhang HX, Fan HY. Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat mammary tumorigenesis. Cancer Epidemiol 2009;33:51-5.
12. Algul H, Treiber M, Lesina M, Schmid RM. Mechanisms of disease: chronic inflammation and cancer in the pancreas - a potential role for pancreatic stellate cells? Nat Clin Pract Gastroenterol Hepatol 2007;4:454-62. (Pubitemid 47208895)
13. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004;36:1031-7. (Pubitemid 38501555)
14. Haddow A. Addendum to "molecular repair, wound healing, and carcinogenesis: tumor production a possible overheating"? Adv Cancer Res 1974;20:343-66.
15. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45. (Pubitemid 32173595)
16. Whitcomb DC, Pogue-Geile K. Pancreatitis as a risk for pancreatic cancer. Gastroenterol Clin North Am 2002;31:663-78. (Pubitemid 34761231)
17. Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernandez-Porras I, Canamero M et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011;19:728-39.
18. Daniluk J, Liu Y, Deng D, Chu J, Huang H, Gaiser S et al. An NF-kappaB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest 2012;122:1519-28.
19. Grote VA, Kaaks R, Nieters A, Tjonneland A, Halkjaer J, Overvad K et al. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer 2012;106:1866-74.
20. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998;280:1036-7. (Pubitemid 28234937)
21. Dite P, Hermanova M, Trna J, Novotny I, Ruzicka M, Liberda M et al. The role of chronic inflammation: chronic pancreatitis as a risk factor of pancreatic cancer. Dig Dis 2012;30:277-83.
22. Farrow B, Sugiyama Y, Chen A, Uffort E, Nealon W, Mark EB. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg 2004;239:763-9.
23. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5. (Pubitemid 26338792)
24. Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
25. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653-8. (Pubitemid 28402089)
26. Deng X, Wang L, Elm MS, Gabazadeh D, Diorio GJ, Eagon PK et al. Chronic alcohol consumption accelerates fibrosis in response to cerulein-induced pancreatitis in rats. Am J Pathol 2005;166:93-106. (Pubitemid 40051663)
27. Maisonneuve P, Lowenfels AB, Mullhaupt B, Cavallini G, Lankisch PG, Andersen JR et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut 2005;54:510-4. (Pubitemid 40395503)
28. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, Dimagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001;286:169-70. (Pubitemid 32640846)
29. Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009;169:1035-45.
30. Pandol SJ, Raraty M. Pathobiology of alcoholic pancreatitis. Pancreatology 2007;7:105-14. (Pubitemid 47094078)
31. Pandol SJ, Periskic S, Gukovsky I, Zaninovic V, Jung Y, Zong Y et al. Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology 1999;117:706-16. (Pubitemid 29409258)
32. Gerasimenko OV, Gerasimenko JV. Mitochondrial function and malfunction in the pathophysiology of pancreatitis. Pflugers Arch 2012;464:89-99.
33. Bhatia V, Kim SO, Aronson JF, Chao C, Hellmich MR, Falzon M. Role of parathyroid hormone-related protein in the pro-inflammatory and pro-fibrogenic response associated with acute pancreatitis. Regul Pept 2012;175:49-60.
34. Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, Batra SK. Interplay between Smoking-induced Genotoxicity and Altered Signaling in Pancreatic Carcinogenesis. Carcinogenesis 2012;33:1617-28.
35. Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 2006;101:148-59. (Pubitemid 43381723)
36. van Geenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ. Smoking is related to pancreatic fibrosis in humans. Am J Gastroenterol 2011;106:1161-6.
37. Malfertheiner P, Schutte K. Smoking - a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol 2006;101:160-2. (Pubitemid 43381724)
38. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-80. (Pubitemid 46693756)
39. Sell H, Habich C, Eckel J. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 2012.(Epub ahead of print)
40. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-84. (Pubitemid 46048464)
41. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009;15:921-9.
42. Duffaut C, Zakaroff-Girard A, Bourlier V, Decaunes P, Maumus M, Chiotasso P et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol 2009;29:1608-14.
43. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:3-10. (Pubitemid 27009941)
44. Li D. Diabetes and pancreatic cancer. Mol Carcinog 2012;51:64-74.
45. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de AM et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008;134:95-101. (Pubitemid 350309328)
46. Li J, Cao G, Ma Q, Liu H, Li W, Han L. The bidirectional interation between pancreatic cancer and diabetes. World J Surg Oncol 2012;10:171.
47. Ramudo L, Yubero S, Manso MA, Vicente S, De D, I. Signal transduction of MCP-1 expression induced by pancreatitis-associated ascitic fluid in pancreatic acinar cells. J Cell Mol Med 2009;13:1314-20.
48. Ramnath RD, Sun J, Bhatia M. Involvement of SRC family kinases in substance P-induced chemokine production in mouse pancreatic acinar cells and its significance in acute pancreatitis. J Pharmacol Exp Ther 2009;329:418-28.
49. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012;148:349-61.
50. Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007;117:50-9. (Pubitemid 46048449)
51. Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, Williams EJ et al. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol 2002;160:1787-98. (Pubitemid 34525658)
52. Keane MP, Strieter RM. The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease. Respir Res 2002;3:5.
53. Tjomsland V, Spangeus A, Valila J, Sandstrom P, Borch K, Druid H et al. Interleukin 1alpha sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts. Neoplasia 2011;13.664-75.
54. Hiraoka N, Yamazaki-Itoh R, Ino Y, Mizuguchi Y, Yamada T, Hirohashi S et al. CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology ;140:310-21.
55. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011;60:1419-30.
56. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007;67:9518-27. (Pubitemid 47535942)
57. Dineen SP, Lynn KD, Holloway SE, Miller AF, Sullivan JP, Shames DS et al. Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. Cancer Res 2008;68:4340-6.
58. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2011;167:e211-e219.
59. De ML, Reni M, Tassi E, Clavenna D, Papa I, Recalde H et al. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 2011;208:469-78.
60. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt RW et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007;25:193-219. (Pubitemid 46697907)
61. Ochi A, Nguyen AH, Bedrosian AS, Mushlin HM, Zarbakhsh S, Barilla R et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp Med 2012;209:1671-87.
62. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999;190:1375-82.
63. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002;10:153-69. (Pubitemid 34520439)
64. Blanquicett C, Saif MW, Buchsbaum DJ, Eloubeidi M, Vickers SM, Chhieng DC et al. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. Clin Cancer Res 2005;11:8773-81. (Pubitemid 43005928)
65. Dragovich T, Burris H, III, Loehrer P, Von Hoff DD, Chow S, Stratton S et al. Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial. Am J Clin Oncol 2008;31:157-62. (Pubitemid 351519167)
66. Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 2002;19:247-58. (Pubitemid 34553525)
67. Harris RE, Beebe-Donk J, Doss H, Burr DD. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 2005;13:559-83.
68. Mamytbekova A, Rezabek K, Kacerovska H, Grimova J, Svobodova J. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. Neoplasma 1986;33:417-21. (Pubitemid 17199521)
69. Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008;12:1-278.
70. Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang SH et al. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res 2010;16:509-20.
71. Seo JY, Masamune A, Shimosegawa T, Kim H. Protective effect of lycopene on oxidative stress-induced cell death of pancreatic acinar cells. Ann N Y Acad Sci 2009;1171:570-5.
72. Moore F, Santin I, Nogueira TC, Gurzov EN, Marselli L, Marchetti P et al. The transcription factor C/EBP delta has anti-apoptotic and anti-inflammatory roles in pancreatic beta cells. PLoS One 2012;7:e31062.
73. Surh YJ, Bode AM, Dong Z. Breaking the NF-kappaB and STAT3 alliance inhibits inflammation and pancreatic tumorigenesis. Cancer Prev Res (Phila) 2010;3:1379-81.
74. Liu A, Liu Y, Li PK, Li C, Lin J. LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells. Anticancer Res 2011;31:2029-35.
75. Shimazaki N, Togashi N, Hanai M, Isoyama T, Wada K, Fujita T et al. Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model. Eur J Cancer 2008;44:1734-43.
76. Chadha MK, Litwin A, Levea C, Iyer R, Yang G, Javle M et al. Surgical resection after TNFerade therapy for locally advanced pancreatic cancer. JOP 2009;10:535-8.
77. Murugesan SR, King CR, Osborn R, Fairweather WR, O'Reilly EM, Thornton MO et al. Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer. Cancer Gene Ther 2009;16:841-7.
78. Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2008,68:1443-50. (Pubitemid 351346852)
79. Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011;331:1612-6.
80. Wu YM, Nowack DD, Omenn GS, Haab BB. Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. J Proteome Res 2009;8:1876-86.
81. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A 2001;98:3352-7. (Pubitemid 32220849)
82. Crowley-Weber CL, Dvorakova K, Crowley C, Bernstein H, Bernstein C, Garewal H et al. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact 2003;145:53-66. (Pubitemid 36246610)
83. Holcomb B, Yip-Schneider M, Schmidt CM. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy. Pancreas 2008;36:225-35. (Pubitemid 351440925)
84. Kaidashev IP. [NF-kB activation as a molecular basis of pathological process by metabolic syndrome]. Fiziol Zh 2012;58:93-101.
85. Pini M, Rhodes DH, Castellanos KJ, Hall AR, Cabay RJ, Chennuri R et al. Role of IL-6 in the resolution of pancreatitis in obese mice. J Leukoc Biol 2012,91:957-66.
86. Fukuda A, Wang SC, Morris JP, Folias AE, Liou A, Kim GE et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011;19:441-55.
87. Albazaz R, Verbeke CS, Rahman SH, McMahon MJ. Cyclooxygenase-2 expression associated with severity of PanIN lesions: a possible link between chronic pancreatitis and pancreatic cancer. Pancreatology 2005;5:361-9. (Pubitemid 41160273)
88. Hermanova M, Trna J, Nenutil R, Dite P, Kala Z. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions. Eur J Gastroenterol Hepatol 2008;20:732-9.
89. Hsieh PS, Jin JS, Chiang CF, Chan PC, Chen CH, Shih KC. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring) 2009;17:1150-7.
90. Song Z, Bhagat G, Quante M, Baik GH, Marrache F, Tu SP et al. Potential carcinogenic effects of cigarette smoke and Swedish moist snuff on pancreas: a study using a transgenic mouse model of chronic pancreatitis. Lab Invest 2010;90:426-35.
91. Takahashi M, Mutoh M, Ishigamori R, Fujii G, Imai T. Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents. Semin Immunopathol 2012 (Epub ahead of print).
92. Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS et al. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract 2012;97:251-7.
93. Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta 2012;1826:129-69.
94. Verma G, Bhatia H, Datta M. Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1beta in human pancreatic cancer cells: role of JNK. Cancer Lett 2012;320:86-95.
95. Maedler K, Dharmadhikari G, Schumann DM, Storling J. Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes. Handb Exp Pharmacol 2011;257-78.
96. Sliwinska-Mosson M, Milnerowicz H, Jablonowska M, Milnerowicz S, Nabzdyk S, Rabczynski J. The effect of smoking on expression of IL-6 and antioxidants in pancreatic fluids and tissues in patients with chronic pancreatitis. Pancreatology 2012;12:295-304.
97. Tjomsland V, Niklasson L, Sandstrom P, Borch K, Druid H, Bratthall C et al. The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma. Clin Dev Immunol 2011;21:2810.
98. Zhu Y, Colak T, Shenoy M, Liu L, Mehta K, Pai R et al. Transforming growth factor beta induces sensory neuronal hyperexcitability, and contributes to pancreatic pain and hyperalgesia in rats with chronic pancreatitis. Mol Pain 2012;8:65.
99. Yadav H, Quijano C, Kamaraju AK, Gavrilova O, Malek R, Chen W et al. Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab 2011;14:67-79.
100. Wang H, Wu J, Zhang Y, Xue X, Tang D, Yuan Z et al. Transforming growth factor beta-induced epithelial-mesenchymal transition increases cancer stem-like cells in the PANC-1 cell line. Oncol Lett 2012;3:229-33.
101. Cho N, Momose Y. Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress. Curr Top Med Chem 2008;8:1483-507.
102. Eibl G. The Role of PRAR-gamma and Its Interaction with COX-2 in Pancreatic Cancer. PPAR Res 2008;2008:326915.
103. Fesinmeyer MD, Stanford JL, Brentnall TA, Mandelson MT, Farin FM, Srinouanprachanh S et al. Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study. Pancreas 2009;38:631-7.
104. Nakajima A, Tomimoto A, Fujita K, Sugiyama M, Takahashi H, Ikeda I et al. Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility. Cancer Sci 2008,99:1892-900.
105. Tandon RK, Garg PK. Oxidative stress in chronic pancreatitis: pathophysiological relevance and management. Antioxid Redox Signal 2011;15:2757-66.
106. Katiyar SK, Meeran SM. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. Free Radic Biol Med 2007;42:299-310. (Pubitemid 44970534)
107. Armstrong AW, Armstrong EJ, Fuller EN, Sockolov ME, Voyles SV. Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol 2011;165:1162-8.
108. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603-16.